<!--StartFragment--><div><p align="center" style="text-align:center;"><span style="font-family:宋体;font-size:10.5000pt;"><span>中科新知</span>&amp;<span>中山三院举行</span><span>COPD</span><span>临床精准用药项目</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p><span style="font-family:宋体;font-size:10.5000pt;"><span>近日，广州中科新知科技有限公司（以下简称中科新知）董事长庞志强与广州中山大学附属第三医院（以下简称中山三院）呼吸科副主任周宇麒出席慢性阻塞性肺疾病（以下简称</span>COPD)<span>临床精准用药项目签约仪式。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p style="text-align: center;"><img width="547" height="348" src="http://www.senviv.com/908.files/908121.png" data-ke-src="http://www.senviv.com/908.files/908121.png"><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p><p><span style="font-family:宋体;font-size:10.5000pt;"><span>双方希望在</span>COPD</span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;"><span>神经分型、临床用药指导、离院连续监测</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>方面进行深度合作，最终做到</span>COPD<span>患者的</span></span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;"><span>筛查预警、急性加重前的预测及临床精准用药</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>，为全球</span>4<span>亿多患者带去福音。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;">COPD<span>是一种以持</span></span><span style="font-family:Calibri;font-size:10.5000pt;"><span>续进行性加重的气流受限为特征的可以预防和治疗的疾病，是成人中最常见的慢性疾病之一，其死亡率及发病率每年持续上升，</span></span><span style="font-family:宋体;font-size:10.5000pt;"><span>到</span>2</span><span style="font-family:Calibri;font-size:10.5000pt;">020<span>年可能成为全世界</span></span><b><span style="font-family:Calibri;font-weight:bold;font-size:10.5000pt;"><span>死亡率第三高发</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>的疾病。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;">2018<span>年，由王辰院士团队完成的大规模人群研究“中国成人肺部健康研究”首项成果发表于国际权威杂志《柳叶刀》上，研究结果显示，我国慢阻肺患者已经超约</span></span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;">1<span>亿人</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>，成为仅次于高血压、糖尿病的中国第三大常见慢性病，相比于</span>2010<span>年，整整上涨了</span></span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;">67%</span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p align="center" style="text-align:center;"><img width="472" height="242" src="http://www.senviv.com/908.files/908417.png" data-ke-src="http://www.senviv.com/908.files/908417.png"><span style="font-family:宋体;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;"><span>一直以来，</span>COPD<span>临床用药一直是一个国际性的老大难问题。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"><span>目前主要依据肺功能检查来确立诊断和指导治疗，但临床上发现这种疾病具有</span></span><b><span style="font-family:Calibri;font-weight:bold;font-size:10.5000pt;"><span>显著的异质性</span></span></b><span style="font-family:Calibri;font-size:10.5000pt;"><span>，患者临床表现、肺功能改变、影像学表现、疾病的演进及对治疗的反应存在明显的差异。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p style="text-align:left;"><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:Calibri;font-size:10.5000pt;"><span>虽然指南推荐对于相同严重程度的患者可以选择同一种治疗方案，然而临床实践发现并非所有患者都能呈现良好的反应</span></span><span style="font-family:宋体;font-size:10.5000pt;"><span>。大多数时候要根据</span></span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;"><span>医生的经验和患者主观感受</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>来调整用药，缺乏</span></span><b><span style="font-family:宋体;font-weight:bold;font-size:10.5000pt;"><span>客观评价</span></span></b><span style="font-family:宋体;font-size:10.5000pt;"><span>，大大增加了管控难度。</span></span><span style="font-family:Calibri;font-size:10.5000pt;"></span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;">“因为肺功能检查普及率不高，很多患者都不知道自己患病，错过了早期最佳的检查机会。很多患者就算接受治疗，肺功能也会毫无征兆就突然出现断崖式的下降。这不仅大大影响了患者的生活质量，更给临床治疗带来了巨大的挑战”中山三院呼吸科周宇麒主任说到。</span><span style="font-family:宋体;font-size:10.5000pt;"></span></p><p align="center" style="text-align:center;"><img width="487" height="325" src="http://www.senviv.com/908.files/908746.png" data-ke-src="http://www.senviv.com/908.files/908746.png"><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;"><span>所以如何对</span>COPD<span>患者进行连续监测及精准用药的指导是目前的重中之重，这不仅能极大提高</span><span>COPD</span><span>患者生活质量，对临床治疗也具有跨时代的意义。</span></span><span style="font-family:宋体;font-size:10.5000pt;"></span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;font-size:10.5000pt;"><span>这次合作也可谓是强强联手。中山三院始建于</span>1971<span>年，</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>是国家卫生部直管的综合性三级甲等医院</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>，</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>也是</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>国家卫健委公布</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>的</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>首批肿瘤多学科诊疗试点医院</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>。</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>疫情期间，周宇麒主任作为首批援鄂医疗队队长，充分发扬了中山三院</span>“医德至上，博积精勤”的医者精神，为抗疫打下了坚实的基础。</span><span style="font-family:Arial;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"></span></p><p style="text-align:left;"><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>中科新知作为中科院院属企业，本次疫情也一直坚守在抗疫一线。仅用</span></span><b><span style="font-family:宋体;color:#333333;font-weight:bold;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>四天时间</span></span></b><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>就区分了普通肺炎和新冠肺炎，在武汉金银潭医院，汉口医院，深圳第三人民医院，南方医院等国内知名医院开展新冠肺炎预后患者及医护人员的健康监测与评估，产品获得</span></span><b><span style="font-family:宋体;color:#333333;font-weight:bold;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>金银潭医院张定宇院长及中科院的高度评价</span></span></b><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>。</span></span><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"></span></p><p style="text-align:left;"><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;">&nbsp;</span></p><p style="text-align:left;"><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>凭借广州中科新知科技有限公司在</span></span><b><span style="font-family:宋体;color:#333333;font-weight:bold;font-style:normal;font-size:10.5000pt;background:#FFFFFF;">AI<span>大数据医疗领域</span></span></b><span style="font-family:宋体;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"><span>的深耕和中山三院在临床领域的丰富经验，我们相信本次项目必将取得圆满成功，实现</span>COPD<span>精准防诊治领域的巨大突破！</span></span><span style="font-family:Arial;color:#333333;font-style:normal;font-size:10.5000pt;background:#FFFFFF;"></span></p><p style="text-align:left;"><span style="font-family:Calibri;font-size:10.5000pt;">&nbsp;</span></p></div><!--EndFragment-->